CA2218616C - Nitrosylated neuropeptides - Google Patents

Nitrosylated neuropeptides Download PDF

Info

Publication number
CA2218616C
CA2218616C CA002218616A CA2218616A CA2218616C CA 2218616 C CA2218616 C CA 2218616C CA 002218616 A CA002218616 A CA 002218616A CA 2218616 A CA2218616 A CA 2218616A CA 2218616 C CA2218616 C CA 2218616C
Authority
CA
Canada
Prior art keywords
smooth muscle
composition
compound
medicament
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002218616A
Other languages
English (en)
French (fr)
Other versions
CA2218616A1 (en
Inventor
Jonathan Stamler
Inigo Saenz De Tejada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston University
Brigham and Womens Hospital Inc
Original Assignee
Boston University
Brigham and Womens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston University, Brigham and Womens Hospital Inc filed Critical Boston University
Publication of CA2218616A1 publication Critical patent/CA2218616A1/en
Application granted granted Critical
Publication of CA2218616C publication Critical patent/CA2218616C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA002218616A 1995-04-21 1996-04-10 Nitrosylated neuropeptides Expired - Fee Related CA2218616C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/426,935 US5612314A (en) 1995-04-21 1995-04-21 Nitrosylated neuropeptides
US08/426,935 1995-04-21
PCT/US1996/004850 WO1996032954A1 (en) 1995-04-21 1996-04-10 Nitrosylated neuropeptides

Publications (2)

Publication Number Publication Date
CA2218616A1 CA2218616A1 (en) 1996-10-24
CA2218616C true CA2218616C (en) 2001-06-19

Family

ID=23692802

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002218616A Expired - Fee Related CA2218616C (en) 1995-04-21 1996-04-10 Nitrosylated neuropeptides

Country Status (7)

Country Link
US (1) US5612314A (enExample)
EP (1) EP0822826B1 (enExample)
JP (1) JP3915125B2 (enExample)
AU (1) AU705533B2 (enExample)
CA (1) CA2218616C (enExample)
DE (1) DE69615171D1 (enExample)
WO (1) WO1996032954A1 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932538A (en) * 1996-02-02 1999-08-03 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
US6469065B1 (en) 1996-02-02 2002-10-22 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use
US6294517B1 (en) 1996-02-02 2001-09-25 Nitromed, Inc. Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use
US5994294A (en) * 1996-02-02 1999-11-30 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
US20020143007A1 (en) * 1996-02-02 2002-10-03 Garvey David S. Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
US6323211B1 (en) 1996-02-02 2001-11-27 Nitromed, Inc. Compositions and methods for treating sexual dysfunctions
US20050065161A1 (en) * 1996-02-02 2005-03-24 Nitromed, Inc. Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
US5910482A (en) * 1996-03-19 1999-06-08 Board Of Regents, The University Of Texas System Treatment or prevention of preeclampsia, eclampsia with calcitonin gene related peptide, CGRP analog, progestational agent, nitric oxide source, and cyclooxygenase inhibitor
EP0942728A1 (en) * 1996-12-02 1999-09-22 MERCK SHARP & DOHME LTD. Use of nk-1 receptor antagonists for treating sexual dysfunction
US6617355B1 (en) * 1997-05-21 2003-09-09 The University Of Virginia Patent Foundation Treating asthma by preventing and/or accomodating S-nitrosothiol breakdown
CA2295595A1 (en) 1997-07-09 1999-01-21 Androsolutions, Inc. Improved methods and compositions for treating male erectile dysfunction
US6103765A (en) * 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
US20020099003A1 (en) * 1997-10-28 2002-07-25 Wilson Leland F. Treatment of female sexual dysfunction with vasoactive agents, particularly vasoactive intestinal polypeptide and agonists thereof
US6207855B1 (en) 1998-06-23 2001-03-27 Duke University Medical Center Stable no-delivering compounds
IL139454A0 (en) 1999-11-08 2001-11-25 Pfizer Compounds for the treatment of female sexual dysfunction
US20050070499A1 (en) * 1999-11-08 2005-03-31 Pfizer Inc. Compounds for the treatment of female sexual dysfunction
US6417347B1 (en) * 2000-08-24 2002-07-09 Scimed Life Systems, Inc. High yield S-nitrosylation process
AU2002326573B2 (en) * 2001-08-20 2008-10-02 University Of Louisville Research Foundation, Inc. Use of S-nitrosothiol signaling to treat disordered control of breathing
EP1468021A2 (en) * 2002-01-26 2004-10-20 Mondobiotech Laboratories Anstalt Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of chronic obstructive pulmonary disease
WO2004091649A1 (en) * 2003-04-14 2004-10-28 Immuneregen Biosciences, Inc. Acute respiratory syndromes
KR100715816B1 (ko) 2006-03-09 2007-05-08 부경대학교 산학협력단 가물치 피부 조직 유래 신경성 펩티드 및 그 유사체
US8626299B2 (en) * 2008-01-31 2014-01-07 Enopace Biomedical Ltd. Thoracic aorta and vagus nerve stimulation
US8626290B2 (en) 2008-01-31 2014-01-07 Enopace Biomedical Ltd. Acute myocardial infarction treatment by electrical stimulation of the thoracic aorta
US9005106B2 (en) * 2008-01-31 2015-04-14 Enopace Biomedical Ltd Intra-aortic electrical counterpulsation
US8538535B2 (en) 2010-08-05 2013-09-17 Rainbow Medical Ltd. Enhancing perfusion by contraction
KR101130283B1 (ko) 2009-07-22 2012-03-26 부경대학교 산학협력단 평활근 이완활성을 지닌 칼시토닌 관련 펩타이드
US8649863B2 (en) 2010-12-20 2014-02-11 Rainbow Medical Ltd. Pacemaker with no production
US8855783B2 (en) 2011-09-09 2014-10-07 Enopace Biomedical Ltd. Detector-based arterial stimulation
WO2013035092A2 (en) 2011-09-09 2013-03-14 Enopace Biomedical Ltd. Wireless endovascular stent-based electrodes
US9386991B2 (en) 2012-02-02 2016-07-12 Rainbow Medical Ltd. Pressure-enhanced blood flow treatment
WO2015068167A2 (en) 2013-11-06 2015-05-14 Enopace Biomedical Ltd. Wireless endovascular stent-based electrodes
US11400299B1 (en) 2021-09-14 2022-08-02 Rainbow Medical Ltd. Flexible antenna for stimulator

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL101406A (en) * 1991-03-29 1998-02-08 Brigham & Womens Hospital Pharmaceutical compositions containing s-nitrosothiol derivatives
US5380758A (en) * 1991-03-29 1995-01-10 Brigham And Women's Hospital S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
DE69233491T2 (de) * 1991-11-14 2006-04-06 The Brigham And Women's Hospital Inc., Boston Pharmazeutische Zusammensetzung enthaltend S-Nitrosolipoproteine und deren Verwendung
US5508045A (en) * 1992-10-09 1996-04-16 The Regents Of The University Of California Method and agents for control and management of labor during pregnancy
US5439938A (en) * 1993-04-07 1995-08-08 The Johns Hopkins University Treatments for male sexual dysfunction

Also Published As

Publication number Publication date
DE69615171D1 (de) 2001-10-18
EP0822826A1 (en) 1998-02-11
WO1996032954A1 (en) 1996-10-24
EP0822826B1 (en) 2001-09-12
AU705533B2 (en) 1999-05-27
AU5446996A (en) 1996-11-07
US5612314A (en) 1997-03-18
JP3915125B2 (ja) 2007-05-16
JPH11504008A (ja) 1999-04-06
EP0822826A4 (enExample) 1998-02-25
CA2218616A1 (en) 1996-10-24

Similar Documents

Publication Publication Date Title
CA2218616C (en) Nitrosylated neuropeptides
Himick et al. CCK/gastrin-like immunoreactivity in brain and gut, and CCK suppression of feeding in goldfish
US6307017B1 (en) Octapeptide bombesin analogs
US6239107B1 (en) Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (VIP)
DK150146B (da) Analogifremgangsmaade til fremstilling af somatostatinanaloge hepta- eller octapeptider eller salte eller complexer deraf
KR20090098843A (ko) 신규 화합물 및 식습관에 대한 이의 효과
CA2218173A1 (en) Analogs of growth hormone-releasing factor
US5217955A (en) Treatment of cancer with peptide analog of bombesin, grp, litorin or neuromedin
PL193236B1 (pl) Zastosowania amyliny lub agonisty amyliny
KR20120127610A (ko) 신규 화합물 및 식습관에 대한 이의 효과
JPH09506616A (ja) 拮抗活性を有するｈＧＨ−ＲＨ（１−２９）ＮＨ▲下２▼の類似体
EP1133522A1 (en) Antagonistic analogs of gh-rh inhibiting igf-i and -ii
AU631547B2 (en) Treatment of arthritis
EP0807639B1 (en) Cyclic motilin-like polypeptides with gastrointestinal motor stimulating activity
US5736517A (en) Treatment of cancer with peptides
CN101578107A (zh) 新颖化合物及其对进食行为的影响
US5422341A (en) Motilin-like polypeptides with gastrointestinal motor stimulating activity
US20070287665A1 (en) Urotensin-II agonists and antagonists
JP2002522355A (ja) 新規な混合アミリン活性化合物
EP0383856B1 (en) Use of peptides for inhibiting blood vessel blockage
EP1214347A2 (en) Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs
US5439884A (en) Method of controlling fertilization using bombesin or its agonist
WO2002009739A1 (en) Treatment of ocular disorders with somatostatin analogues

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed